Choroid Plexus Papilloma Incidence in Adults – WHO Data
Choroid Plexus Papilloma Incidence in Adults – WHO Data Choroid plexus papilloma (CPP) is a rare, benign tumor originating from the choroid plexus epithelium within the brain’s ventricular system. While it is more prevalent in children, its occurrence in adults is notably uncommon, making accurate data and awareness vital for diagnosis and management. According to the World Health Organization (WHO), which classifies central nervous system tumors based on histopathological features, CPP is categorized as a WHO Grade I tumor, indicating its generally benign nature with a favorable prognosis after surgical removal.
The incidence of choroid plexus papilloma in adults remains remarkably low, accounting for less than 1% of all brain tumors in this age group. Data from WHO and various epidemiological studies suggest that adult cases comprise approximately 2-5% of all CPP diagnoses observed globally. This rarity can often lead to misdiagnosis or delayed diagnosis, as symptoms tend to be nonspecific and may mimic other neurological conditions. Common presenting symptoms include headache, nausea, vomiting, and signs of increased intracranial pressure, often resulting from cerebrospinal fluid (CSF) overproduction or obstructive hydrocephalus caused by the tumor.
The etiology of CPP in adults is not fully understood, but it is generally thought to arise sporadically. Unlike in pediatric populations, where genetic syndromes such as Li-Fraumeni or familial predispositions may contribute, adult cases rarely exhibit such associations. The tumor’s location is predominantly within the lateral ventricles in adults, although it can occasionally be found in the third or fourth ventricles. Imaging modalities such as MRI are crucial for detection, with CPP typically appearing as a well-defined, lobulated mass that enhances vividly after contrast administration.
Surgical resection remains the primary treatment modality for adult CPP, often resulting in complete tumor removal and excellent prognosis. The WHO emphasizes the importance of thorough histopathological examination to confirm diagnosis and rule out malignancy, as choroid plexus carcinomas (WHO Grade III) are more aggressive and require adjuvant therapies. Recurrence after complete resection is rare but necessitates ongoing follow-up, especially considering the potential for hydrocephalus or other complications.
The low incidence of CPP in adults underscores the need for heightened clinical suspicion and comprehensive diagnostic evaluation. While the overall prognosis is favorable, early detection and surgical intervention are critical to prevent neurological deficits and improve quality of life. Ongoing research and accumulation of epidemiological data continue to refine understanding of its pathogenesis, optimal management strategies, and long-term outcomes in adult patients.
In summary, choroid plexus papilloma in adults is a rare tumor with specific clinical and radiological features. WHO data highlight its low incidence, underscore its benign nature, and emphasize the importance of surgical treatment for a positive prognosis. Awareness and early intervention are key to managing this uncommon but treatable condition effectively.
